These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6886974)

  • 21. Skin deep.
    Hadgraft J
    Eur J Pharm Biopharm; 2004 Sep; 58(2):291-9. PubMed ID: 15296956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting skin permeability from complex chemical mixtures.
    Riviere JE; Brooks JD
    Toxicol Appl Pharmacol; 2005 Oct; 208(2):99-110. PubMed ID: 16183383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A biophysically based dermatopharmacokinetic compartment model for quantifying percutaneous penetration and absorption of topically applied agents. I. Theory.
    Williams PL; Riviere JE
    J Pharm Sci; 1995 May; 84(5):599-608. PubMed ID: 7658351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin.
    Nielsen JB; Nielsen F; Sørensen JA
    Arch Dermatol Res; 2007 Nov; 299(9):423-31. PubMed ID: 17882442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The usual suspects-influence of physicochemical properties on lag time, skin deposition, and percutaneous penetration of nine model compounds.
    Bo Nielsen J; Ahm Sørensen J; Nielsen F
    J Toxicol Environ Health A; 2009; 72(5):315-23. PubMed ID: 19184747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of drug penetration through skin considering donor concentration decrease.
    Hashida M; Okamoto H; Sezaki H
    J Pharmacobiodyn; 1988 Sep; 11(9):636-44. PubMed ID: 3216285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finite dose percutaneous drug absorption: a BASIC program for the solution of the diffusion equation.
    Kubota K
    Comput Biomed Res; 1991 Apr; 24(2):196-207. PubMed ID: 1903685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical aspects of percutaneous penetration and its enhancement.
    Guy RH; Hadgraft J
    Pharm Res; 1988 Dec; 5(12):753-8. PubMed ID: 3247284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling skin penetration using the Laplace transform technique.
    Anissimov YG; Watkinson A
    Skin Pharmacol Physiol; 2013; 26(4-6):286-94. PubMed ID: 23921115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mathematical models for dermal drug absorption.
    Selzer D; Neumann D; Schaefer UF
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1567-83. PubMed ID: 26166490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous penetration paradigms: the contribution of Jonathan Hadgraft.
    Lane ME
    Skin Pharmacol Physiol; 2013; 26(4-6):277-85. PubMed ID: 23921114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human skin.
    Schaefer H; Stüttgen G; Zesch A; Schalla W; Gazith J
    Curr Probl Dermatol; 1978; 7():80-94. PubMed ID: 752460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal drug delivery in vitro using diffusion cells.
    Bartosova L; Bajgar J
    Curr Med Chem; 2012; 19(27):4671-7. PubMed ID: 22934776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vehicle effects in percutaneous absorption.
    Idson B
    Drug Metab Rev; 1983; 14(2):207-22. PubMed ID: 6341025
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on drug absorption from oral cavity: physicochemical factors affecting absorption from hamster cheek pouch.
    Kurosaki Y; Aya N; Okada Y; Nakayama T; Kimura T
    J Pharmacobiodyn; 1986 Mar; 9(3):287-96. PubMed ID: 3723320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mathematical model of drug absorption.
    Goodacre BC; Murray PJ
    J Clin Hosp Pharm; 1981 Jun; 6(2):117-33. PubMed ID: 7343561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of drug disposition kinetics in skin and plasma following topical administration.
    Guy RH; Hadgraft J
    J Pharm Sci; 1984 Jul; 73(7):883-7. PubMed ID: 6470948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.
    Wester RC; Maibach HI
    Drug Metab Rev; 1983; 14(2):169-205. PubMed ID: 6341024
    [No Abstract]   [Full Text] [Related]  

  • 39. Review of theoretical passive drug absorption models: historical background, recent developments and limitations.
    Camenisch G; Folkers G; van de Waterbeemd H
    Pharm Acta Helv; 1996 Nov; 71(5):309-27. PubMed ID: 8973162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A two-dimensional mathematical model of percutaneous drug absorption.
    George K; Kubota K; Twizell EH
    Biomed Eng Online; 2004 Jun; 3(1):18. PubMed ID: 15202943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.